A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Instituto do Cancer do Estado de São Paulo
EMD Serono
National Institutes of Health Clinical Center (CC)
Institut Claudius Regaud
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Duke University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Bayer
Second Affiliated Hospital, School of Medicine, Zhejiang University
University Hospital Heidelberg
Tango Therapeutics, Inc.
Washington University School of Medicine
STORM Therapeutics LTD
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Turning Point Therapeutics, Inc.
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Medical University of South Carolina
Second Affiliated Hospital, School of Medicine, Zhejiang University
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Italian Sarcoma Group
Inhibrx Biosciences, Inc
Centre Oscar Lambret
Roswell Park Cancer Institute
Ratio Therapeutics, Inc.
Universitaire Ziekenhuizen KU Leuven
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Novartis
QBiotics Group Limited
University of Florida
Jonsson Comprehensive Cancer Center
University Hospital Heidelberg
City of Hope Medical Center
Wake Forest University Health Sciences
Zai Lab (Hong Kong), Ltd.
University Health Network, Toronto
University of California, Irvine
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center